The
U.S. Patent and Trademark Office has announced the agenda for the next
biotechnology/chemical/pharmaceutical (BCP) customer partnership meeting to be
held on June 1, 2010.  The proposed
agenda is as follows:

Morning
Session

•
Greetings and Overview (10:00 – 10:15 am EDT):  George Elliott and Remy Yucel, Directors, Technology Center
1600

•
Reexam Best Practice (10:15 – 11:15 am): 
CRU

•
Ombudsman (11:15 am – 11:40 pm): 
Valencia Martin-Wallace, Director, TC2400

•
Break (11:40 – 11:55 pm)

•
Information Disclosure Statement (11:55 am – 12:40 pm):  Julie Burke, QAS, TC1600

•
Lunch (12:40 – 1:50 pm)

Afternoon
Session

•
Restriction Form Paragraph (1:50 – 2:20 pm):  Julie Burke, QAS, TC1600

•
Break (2:20 – 2:35 pm)

•
A Perspective on Gene Patents (2:35 – 3:35 pm):  Hans Sauer, Associate General Counsel for Intellectual
Property, Biotechnology Industry Organization (BIO)

•
Closing Remarks/Discussion (3:35 – 3:50 pm):  George Elliott and Remy Yucel, Directors, TC1600

The
meeting can be attended in person at the USPTO's Madison Auditorium, 600 Dulany
Street, Alexandria, VA, or viewed online here (select the "enter as
guest" option).  The Patent
Office asks that non-USPTO employees login using their e-mail addresses.